STOCK TITAN

Decibel Therapeutics Inc - DBTX STOCK NEWS

Welcome to our dedicated news page for Decibel Therapeutics (Ticker: DBTX), a resource for investors and traders seeking the latest updates and insights on Decibel Therapeutics.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Decibel Therapeutics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Decibel Therapeutics's position in the market.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.16%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.56%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.31%
Tags
earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.36%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.49%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.39%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.49%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.37%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.98%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.28%
Tags
earnings
Decibel Therapeutics Inc

Nasdaq:DBTX

DBTX Rankings

DBTX Stock Data

123.37M
13.40M
13.36%
61.95%
0.44%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States
Boston

About DBTX

decibel therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair and restore hearing. hearing loss is the most prevalent form of sensory impairment. it is estimated that 50 million people in the u.s., and 360 million people worldwide, suffer from some type of hearing loss. hearing disorders affect people of all ages and can have a profound impact on quality of life. by combining recent innovations in hearing science with leading diagnostic tools, biological insights, modeling and therapeutic delivery techniques, decibel is pioneering a comprehensive approach to defining and treating the underlying biological causes of hearing disorders, and developing a pipeline of breakthrough drugs targeted to specific indications and patients. founded by the world’s preeminent experts in inner ear biology and hearing disorders, decibel therapeutics was launched in 2015 by third rock ventures and sr one and is headquartered in boston, mass. for more inf